On 31 May 2024, the European Medicines Agency (EMA) published the Committee for Medicinal Products for Human Use (CHMP) reflection paper on Creutzfeldt-Jakob disease (CJD) and plasma-derived and urine-derived medicinal products.
In a concerted effort to combat healthcare-associated infections (HAIs) and antimicrobial resistance (AMR), the European Centre for Disease Prevention and Control (ECDC) and the Belgian EU Presidency on 6-7 May co-hosted a conference at the national public health institute of Belgium, Sciensano, in Brussels.
Additional cases of Crimean-Congo haemorrhagic fever (CCHF), a potentially life threatening tick-borne viral disease, have been reported in the EU/EEA, according to new data published by ECDC. Experts have warned of an increased risk of transmission on the continent.
A cross-border outbreak of Salmonella Mbandaka ST413 has been ongoing in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) for over two years since September 2021, as detailed in an updated joint Rapid Outbreak Assessment by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA).
The food-borne infections listeriosis and shigatoxigenic Escherichia coli are increasing in the EU/EEA and were in 2022 at levels higher than before the COVID-19 pandemic.
This report provides an overview of the total number of cases of mpox (monkeypox) reported to ECDC and the WHO Regional Office for Europe through IHR/EWRS mechanisms .
A genomic cluster of Listeria monocytogenes infections has been identified in the EU/EEA and the United Kingdom, according to a Rapid Outbreak Assessment released today by ECDC and EFSA.